Harrow Inc reports results for the quarter ended September 30 - Earnings Summary

Harrow

14/11/2024 03:58

* Harrow Inc  HROW.OQ  reported a quarterly adjusted loss
of 12
cents​​ per share for the quarter ended September 30, higher
than the same quarter last year, when the company reported EPS
of -13 cents.  The mean expectation of four analysts for the
quarter was for a loss of 5 cents per share. Wall Street
expected results to range from -9 cents tozero cents per share.
    * Revenue rose 43.8% to $49.26 million from a year ago;
analysts
expected $52.81 million. 
    * Harrow Inc's reported EPS for the quarter was a loss of 12
cents​.
    * The company reported a quarterly loss of $4.22 million.
    * Harrow Inc shares had risen by 11.0% this quarter and
gained 345.6% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 24%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"

Wall Street's median 12-month price target for Harrow Inc is
$60.00 
This summary was machine generated from LSEG data November 14 at
03:57 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.05          -0.12          Missed
 Jun. 30 2024      -0.20          -0.18          Beat
 Mar. 31 2024      -0.20          -0.38          Missed
 Dec. 31 2023      -0.04          -0.25          Missed